A 52-week extension study showed that the drug continues to maintain favorable body composition with no safety issues.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/lonapegsomatropin-shows-long-term-benefit-adult-ghd-2026a1000cyp?src=rss
Author :
Publish date : 2026-04-23 18:58:00
Copyright for syndicated content belongs to the linked Source.